Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy

Overview of attention for article published in Cancer Immunology, Immunotherapy, December 2004

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

policy: 1 policy source

patent: 165 patents

Citations

dimensions_citation: 499 Dimensions

Readers on

mendeley: 336 Mendeley

Summary Policy documents Patents Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer : Appraisal consultation committee papers

Cited by National Institute for Health and Care Excellence on 19 Dec 2019

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Nivolumab for treating relapsed or refractory classical Hodgkin lymphoma: Committee papers

Cited by National Institute for Health and Care Excellence on 06 Mar 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.